Username:
Password:
   
Create an Account
 
Account
Curriculum
Transcript
Preferences
 
Welcome & Mission Statement
FAQs
User Technical Support
Accreditation Legend
System Requirements
 
AAMC CME
ABMS
ACCME
AHRQ
AMA
CDC
MBC
 
Making the Connection between Patients & Providers: A Comprehensive Overview of the Modern Treatment Strategies for People with Type 1 and Type 2 Diabetes: Nashville, TN. September 8, 2018
Activity Details
Activity Name: Making the Connection between Patients & Providers: A Comprehensive Overview of the Modern Treatment Strategies for People with Type 1 and Type 2 Diabetes: Nashville, TN. September 8, 2018
Course Objectives: At course completion, participants should be able to:

  • Discuss the different pathophysiologic defects associated with type 2 diabetes and how pharmacologic agents address these specific abnormalities.
  • Summarize the recently published cardiovascular outcome trials (CVOTs) on oral and injectable type 2 medications and be able to discuss their implications in terms of clinical application.
  • Discuss approaches to combination therapy with the currently available oral agents including metformin, TZDs, an SFUs, SGLT-2 inhibitors, DPP4 inhibitors as well as GLP-1 receptor agonists.
  • Design rational and individualized treatment plans using mono- or combination therapy, including the optimal time for introducing each therapy.
  • Describe the advantages and limitations of modern insulin preparations and the various clinical strategies including combination therapy, split mixed, premixed, basal-bolus, and pump regimens.
  • Discuss patient-directed insulin titration strategies used in clinical practice for combination therapy and the basal bolus approach.
  • Review and describe the pathophysiology of type 2 diabetes as it relates to the role of newer medications such as incretin-based therapies and SGLT-2 inhibitors.
  • Outline the most up to date clinical information on GLP-1 receptor agonists and SGLT-2 inhibitors, including prescribing guidelines and safety issues.
  • Illustrate the physiologic secretion of insulin, glucagon, and amylin in the normal and diabetic state and propose a physiologic multiple daily injection regimen.
  • Identify appropriate candidates for pump therapy.
  • Location Information
    Meeting Location: Music City Center
    Meeting Location URL: https://tcoyd.org/making-the-connection/detail/cme-nashville-tn-2018-09-08/
    Location Address: 201 5th Avenue South
    Location City: Nashville
    Location State: TN
    Location Postal Code: 37203
    Location Country: US
    Activity Information
    Start Date: 9/8/2018
    End Date: 9/8/2018
    Fees: $50 - $65
    Meeting URL: https://tcoyd.org/making-the-connection/detail/cme-nashville-tn-2018-09-08/
    Credit Information
    Credit Amount: 6.25
    Credit Unit: Credits
    Accreditation: ACCME - Accreditation Council for Continuing Medical Education > AMA PRA Category 1 Credit
    Activity Learning Format: Live Activity
    Accreditor/Sponsor
    Sponsor Name: UC San Diego School of Medicine
    Sponsor Address: 9500 Gilman Drive, MC0947
    Sponsor City: La Jolla
    Sponsor State: CA
    Sponsor Postal Code: 92093
    Sponsor Country: US
    Sponsor Phone: 858-534-3940
    Sponsor Email: ocme@ucsd.edu
    Contact Information
    Contact Name: Taking Control of Your Diabetes (TCOYD)
    Contact Phone: 800-998-2693
    Contact Email: info@tcoyd.org

    Type:     Live Activity
    0 Registered Users